| Product Code: ETC7657003 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neurotherapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neurotherapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neurotherapeutics Market - Industry Life Cycle |
3.4 Israel Neurotherapeutics Market - Porter's Five Forces |
3.5 Israel Neurotherapeutics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Israel Neurotherapeutics Market Revenues & Volume Share, By Disorders, 2021 & 2031F |
3.7 Israel Neurotherapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Neurotherapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Israel |
4.2.2 Growing awareness about the importance of mental health and well-being |
4.2.3 Technological advancements in neurotherapeutics research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for neurotherapeutics approval in Israel |
4.3.2 Limited accessibility and affordability of neurotherapeutics treatments |
4.3.3 Competition from alternative therapies and traditional medicine practices |
5 Israel Neurotherapeutics Market Trends |
6 Israel Neurotherapeutics Market, By Types |
6.1 Israel Neurotherapeutics Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Israel Neurotherapeutics Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Israel Neurotherapeutics Market Revenues & Volume, By Neurological Drugs, 2021- 2031F |
6.1.4 Israel Neurotherapeutics Market Revenues & Volume, By Neurological Devices, 2021- 2031F |
6.2 Israel Neurotherapeutics Market, By Disorders |
6.2.1 Overview and Analysis |
6.2.2 Israel Neurotherapeutics Market Revenues & Volume, By Peripheral Nervous System Disorders (PNS) Disorder, 2021- 2031F |
6.2.3 Israel Neurotherapeutics Market Revenues & Volume, By Autonomous Nervous System (ANS) Disorder, 2021- 2031F |
6.2.4 Israel Neurotherapeutics Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.3 Israel Neurotherapeutics Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Neurotherapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel Neurotherapeutics Market Revenues & Volume, By Neurotherapeutic Centers, 2021- 2031F |
6.3.4 Israel Neurotherapeutics Market Revenues & Volume, By Clinical Research Organizations, 2021- 2031F |
6.3.5 Israel Neurotherapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neurotherapeutics Market Import-Export Trade Statistics |
7.1 Israel Neurotherapeutics Market Export to Major Countries |
7.2 Israel Neurotherapeutics Market Imports from Major Countries |
8 Israel Neurotherapeutics Market Key Performance Indicators |
8.1 Number of clinical trials for neurotherapeutics conducted in Israel |
8.2 Investment in neurotherapeutics research and development in the country |
8.3 Adoption rate of innovative neurotherapeutics treatments in the healthcare system |
9 Israel Neurotherapeutics Market - Opportunity Assessment |
9.1 Israel Neurotherapeutics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Israel Neurotherapeutics Market Opportunity Assessment, By Disorders, 2021 & 2031F |
9.3 Israel Neurotherapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Neurotherapeutics Market - Competitive Landscape |
10.1 Israel Neurotherapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Neurotherapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here